Contact
Email
role · B2B
r•••@a•••.compersonal/unknown · GDPR-sensitive
g•••@e•••.coms•••@k•••.deSocial
Contact page
🔒 Contacts are masked. Get full emails & phones. Unlock via export ↗
Category & trade
Primary
brain-and-nervous-system-disorders · embed-ft 0.22
Tree path
Medical Health › Diseases and Conditions › Brain and Nervous System Disorders
Group (tier-1)
Tech stack
AI readiness
AI-Readiness score
18 / 100 · not-ready · see similar
AI training policy
allowed
Terms of Service
AI-bot protection
AI files
llms.txt ai.txt humans.txt robots.txt
Compliance (GEO / GDPR)
Overview
Title
Ataxia Telangiectasia; rare genetic disease; IEDAT; Erydel; pivotal phase III study; H2020; clinical study
Description
a pivotal phase III study will be conducted, and regulatory filing for market authorization of the therapy in EU and USA will be made by 2019.
Final URL
Language
en (content)
Scanned at
2026-07-07 05:05:44